Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from MicroPort CardioFlow Medtech Corp. ( (HK:2160) ) is now available.
MicroPort CardioFlow Medtech Corp. has proposed a share consolidation that will combine every five existing shares into one consolidated share, raising the par value per share while keeping the company’s total authorised share capital unchanged at US$50,000. Subject to shareholder approval at an extraordinary general meeting and the Hong Kong Stock Exchange’s listing approval, the move would reduce the number of issued shares from about 6.37 billion to roughly 1.27 billion without affecting the board lot size, a technical capital restructuring that could influence trading dynamics and share price optics but does not alter underlying ownership proportions.
The most recent analyst rating on (HK:2160) stock is a Hold with a HK$1.00 price target. To see the full list of analyst forecasts on MicroPort CardioFlow Medtech Corp. stock, see the HK:2160 Stock Forecast page.
More about MicroPort CardioFlow Medtech Corp.
MicroPort CardioFlow Medtech Corp. is a Hong Kong-listed medical technology company focused on cardiovascular intervention solutions, developing and commercialising devices and therapies aimed at treating heart-related conditions in global markets.
Average Trading Volume: 4,813,460
Technical Sentiment Signal: Sell
Current Market Cap: HK$6.56B
See more data about 2160 stock on TipRanks’ Stock Analysis page.